U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07816575) titled 'Comparative Efficacy of Alpha Hydroxy Acids With and Without Nanocarriers Versus Calcipotriol Plus Betamethasone in Treatment of Plaque Psoriasis' on Sept. 08.
Brief Summary: The aim of this double blind comparative clinical study is to evaluate the efficacy of AHAs combined with nanocarriers and their use as a non steroidal alternative drug for long term management of plaque psoriasis
Study Start Date: March 15, 2024
Study Type: INTERVENTIONAL
Condition:
Psoriasis
Intervention:
DRUG: Alpha Hydroxy Acids with nanocarriers
Topical Alpha Hydroxy Acids formulated with nanocarriers applied to psoriatic plaques.
DRUG: Alpha Hydr...